Nitisinone (also known as NTBC, an abbreviation of its full chemical name) is a drug used to slow the effects of hereditary tyrosinemia type 1.
Easy to read patient leaflet for nitisinone. Includes indications, proper use, special instructions, precautions, and possible side effects.
Nitisinone works by preventing the body from breaking down an amino acid called tyrosine and by keeping other toxic substances from building up and causing harm to ...
Learn about the prescription medication Orfadin (Nitisinone), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
Orfadin. Orfadin (nitisinone) is the only FDA approved therapy, for use with dietary restriction of tyrosine and phenylalanine, for the treatment of tyrosinemia type 1.
Nitisinone . Patients who attend the National AKU Centre are commenced on the drug nitisinone. Nitisinone is currently licensed for use in treating another similar ...
Consumer information about the medication NITISINONE - ORAL (Orfadin), includes side effects, drug interactions, recommended dosages, and storage information. Read ...
Swedish Orphan Biovitrum has the worldwide rights to this product. What is Orfadin? Orfadin is a hard white capsule for oral use. Treatment with Orfadin should be ...
In a pioneering trial at Royal Liverpool Hospital, patients with alkaptonuria (AKU) - known as black bone disease - are being given a drug called nitisinone.
Sigma-Aldrich offers Sigma-SML0269, Nitisinone for your research needs. Find product specific information including CAS, MSDS, protocols and references.